G D Ross|M J Polley - JoVE Visualize

Showing results (71-80 of 81) with videos related to

Pageof 9

Sort By:

Clinical and Experimental Immunology|March 1, 1985

Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inheritedM J Walport, G D Ross, C Mackworth-Young, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 1, 1977

Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiationR J Winchester, G D Ross, C I Jarowski, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999

Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18)J Yan, V Vetvicka, Y Xia, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983

Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3dL M Hutt-Fletcher, E Fowler, J D Lambris, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991

Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18)R A Roubey, G D Ross, J T Merrill, et al.

The Journal of Experimental Medicine|August 1, 1983

Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutininG D Ross, S L Newman, J D Lambris, et al.

Leukemia|July 31, 2004

Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cellsM Z Ratajczak, R Reca, M Wysoczynski, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988

Dissociation between increased surface expression of gp165/95 and homotypic neutrophil aggregationJ P Buyon, S B Abramson, M R Philips, et al.

Immunogenetics|January 1, 1990

Synthesis of complement component C5 by human B and T lymphoblastoid cell linesW Reed, R A Roubey, J G Dalzell, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985

Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activationG D Ross, W J Yount, M J Walport, et al.

Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:

Pageof 9

Clinical and Experimental Immunology|March 1, 1985

Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inheritedM J Walport, G D Ross, C Mackworth-Young, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 1, 1977

Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiationR J Winchester, G D Ross, C I Jarowski, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999

Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18)J Yan, V Vetvicka, Y Xia, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983

Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3dL M Hutt-Fletcher, E Fowler, J D Lambris, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991

Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18)R A Roubey, G D Ross, J T Merrill, et al.

The Journal of Experimental Medicine|August 1, 1983

Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutininG D Ross, S L Newman, J D Lambris, et al.

Leukemia|July 31, 2004

Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cellsM Z Ratajczak, R Reca, M Wysoczynski, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988

Dissociation between increased surface expression of gp165/95 and homotypic neutrophil aggregationJ P Buyon, S B Abramson, M R Philips, et al.

Immunogenetics|January 1, 1990

Synthesis of complement component C5 by human B and T lymphoblastoid cell linesW Reed, R A Roubey, J G Dalzell, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985

Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activationG D Ross, W J Yount, M J Walport, et al.

Pageof 9